KLINIČKE UPUTE HRVATSKOGA ONKOLOŠKOG DRUŠTVA ZA DIJAGNOZU, LIJEČENJE I PRAĆENJE BOLESNICA/KA OBOLJELIH OD INVAZIVNOG RAKA DOJKE

Robert Šeparović, Marija Ban, Tajana Silovska, Lidija Beketić Orešković, Željko Soldić, Paula Podolski, Stjepko Pleština, Damir Gugić, Marija Petković, Jasminka Jakić-Razumović, Željko Vojnović, Branka Petrić Miše, Snježana Tomić, Zdenko Stanec, Danko Velemir Vrdoljak, Ivan Drinković, Boris Brkljačić, Elvira Mustać, Ivan Utrobičić, Eduard Vrdoljak

Rak dojke najčešći je zloćudni tumor u žena koji se može probirom, redovitim kontrolama i zdravstvenim odgojem otkriti u ranim stadijima bolesti i uspješno liječiti. Metode liječenja uključuju kirurgiju, kemoterapiju, radioterapiju, hormonsku terapiju i ciljanu biološku terapiju ovisno o stadiju bolesti, biološkim obilježjima tumora i općem stanju bolesnice. Odluku o liječenju donosi multidisciplinarni tim. S obzirom na važnost ove bolesti, potrebno je definirati i provoditi standardizirani pristup u dijagnostici, liječenju i praćenju ovih bolesnica. U tekstu koji slijedi iznesene su kliničke smjernice s ciljem implementacije standardiziranih postupaka u radu s bolesnicama s rakom dojke u Republici Hrvatskoj.

Breast cancer is the most common cancer in women. It can be diagnosed in early stage through screening, early detection and educational programs, and when diagnosed early it can be efficiently treated. Treatment modalities include surgery, chemotherapy, radiotherapy, hormonal therapy and targeted biologic therapy, according to the stage of the disease and patient condition. Treatment decisions should be made after multidisciplinary team discussion. Due to the significance of this disease it is important to define and implement standardized approach for diagnostic, treatment and monitoring algorithm as well. The following text presents the clinical guidelines in order to standardize the procedures and criteria for diagnosis, management, treatment and monitoring of patients with breast cancer in the Republic of Croatia.